An overview of antiviral strategies for coronavirus 2 (SARS‐CoV‐2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine

Author:

Dragojevic Simic Viktorija12ORCID,Miljkovic Milijana12,Stamenkovic Dusica23ORCID,Vekic Berislav456ORCID,Ratkovic Nenad27,Simic Radoje89,Rancic Nemanja12ORCID

Affiliation:

1. Center for Clinical PharmacologyMilitary Medical Academy Belgrade Serbia

2. Faculty of Medicine Military Medical AcademyUniversity of Defence Belgrade Serbia

3. Department of Anesthesiology and Intensive Care Military Medical Academy Belgrade Serbia

4. Department of Surgery Clinical Center Dr. Dragisa Misovic Kragujevac Serbia

5. Faculty of Medical Sciences University of Kragujevac Kragujevac Serbia

6. Ministry of Health of the Republic of Serbia Belgrade Serbia

7. Sector for Treatment Military Medical Academy Belgrade Serbia

8. Department for Plastic Surgery Institute for Mother and Child Health Care of Serbia Dr. Vukan Cupic Belgrade Serbia

9. Faculty of Medicine University of Belgrade Belgrade Serbia

Funder

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja

Publisher

Hindawi Limited

Subject

General Medicine

Reference83 articles.

1. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review

2. What we know so far: COVID-19 current clinical knowledge and research

3. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

4. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020

5. Severe acute respiratory infections treatment Centre: practical manual to set up and manage a SARI treatment centre and SARI screening facility in health care facilities. Geneva: World Health Organization;2020.https://apps.who.int/iris/bitstream/handle/10665/331603/WHO‐2019‐nCoV‐SARI_treatment_center‐2020.1‐eng.pdf?sequence=1&isAllowed=y. Accessed June 23 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3